New Delhi : Global Health Limited, operating under the brand name Medanta, reported a net profit of ₹101.4 crore for the fourth quarter of FY25, marking a 20.4% year-on-year (YoY) decline from ₹127 crore in Q4 FY24. The quarterly profit also reflected a sharp drop from ₹142 crore in the previous quarter (Q3 FY25).
Despite the dip in profit, the company’s total income rose to ₹954.2 crore, with revenue from operations up by 15.2% YoY to ₹931 crore for the quarter ended March 2025.
Q4 Impacted by One-Time Merger Expenses
The decline in quarterly profit was attributed to non-recurring exceptional expense items amounting to ₹49.9 crore, incurred due to the merger of Medanta Hospitals Private Limited (MHPL) with Global Health Limited (GHL).
Operational Highlights: Growth in Occupancy and ARPOB
- Bed Occupancy Rate improved by 12.3% YoY, reaching 61.3%
- Average Revenue Per Occupied Bed (ARPOB) grew marginally by 0.9% YoY, touching ₹63,629
FY25 Financial Performance
For the full fiscal year 2024–25:
- Revenue from operations increased 12.7% to ₹3,692 crore
- Net profit saw a modest rise of 0.7%, totaling ₹481 crore, compared to ₹478 crore in FY24
Expansion Strategy: New Projects and Added Capacity
During the year, Medanta added 219 beds across its network, including:
- 49 beds in Gurugram
- 58 beds in Lucknow
- 112 beds in Patna
The hospital group also approved a ₹500 crore greenfield super-speciality project in Guwahati, and announced that its Noida facility is expected to go operational by September 2025.
CEO’s Outlook: Strategic Growth in High-Potential Markets
Commenting on the group’s future plans, Pankaj Sahni, Group CEO and Director, said:
“The three greenfield projects in Mumbai, Pitampura, and Guwahati will significantly expand our national footprint and diversify our presence across high-growth regions. These are expected to be operational within the next three to four years.”
